Although brachytherapy is an effective treatment modality for gynecological cancer, a
significant proportion of patients develop late treatment-related vaginal toxicity,
negatively impacting their quality of life and limiting recurrent disease detection by
preventing adequate clinical examination during the post-treatment surveillance period.
Consistent with the literature, results from a study at Princess Margaret revealed that
current vaginal toxicity management education and training may be inadequate. The
investigators seek to implement and evaluate a new online brachytherapy discharge
education program (BrachDEP) to support patient engagement in self-management.
